ArticleInternational journal of critical illness and injury science2013
A phase III trial evaluating the efficacy and tolerability of nimesulide 1% spray in patients with soft-tissue injuries.
Mazharuddin Ali Khan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.